https://scholars.lib.ntu.edu.tw/handle/123456789/558897
標題: | Risk of acute kidney injury after transarterial chemoembolisation in hepatocellular carcinoma patients: A nationwide population-based cohort study | 作者: | BO-CHING LEE KAO-LANG LIU Lin C.-L. Kao C.-H. |
公開日期: | 2017 | 卷: | 27 | 期: | 11 | 起(迄)頁: | 4482-4489 | 來源出版物: | European Radiology | 摘要: | Objective: This nationwide population-based cohort study evaluated the association between acute kidney injury (AKI) and transarterial chemoembolisation (TACE) in patients with hepatocellular carcinoma (HCC). Methods: The case cohort included patients with HCC who had undergone TACE treatment between 1 January 1998 and 31 March 2010. Patients with baseline chronic kidney disease, with baseline end-stage renal disease, and aged younger than 20 years were excluded. HCC patients with TACE and HCC patients without TACE were matched 1:1 in terms of propensity scores. Results: A total of 1132 HCC patients with TACE and 1132 HCC patients without TACE (controls) were enrolled, of which 72 and 66 patients developed AKI, respectively. After adjustment for age, sex, comorbidity, and other medications, the risk of AKI was higher in HCC patients with TACE [hazard ratio (HR) = 1.66, 95% CI = 1.17–2.34]. The HRs of post-TACE AKI were 1.56 (95% CI = 1.02–2.37) and 1.74 (95% CI = 1.23–2.48) for patients having at least one comorbidity and less frequent sessions of TACE (?3 times), respectively. Conclusions: Our study demonstrates that TACE increases the risk of AKI in patients with HCC without chronic kidney disease or end-stage renal disease. Key points: ? Seventy-two of1132 patients with TACE and 62/1132 patients without TACE developed AKI. ? AKI risk was higher in HCC patients with TACE. ? HRs were 1.56 and 1.74 for those with comorbidities and less frequent TACE. ? 2017, European Society of Radiology. |
URI: | https://scholars.lib.ntu.edu.tw/handle/123456789/558897 | ISSN: | 0938-7994 | DOI: | 10.1007/s00330-017-4893-x | SDG/關鍵字: | acute kidney failure; adult; aged; Article; cancer patient; chemoembolization; cohort analysis; comorbidity; controlled study; female; follow up; hazard ratio; high risk patient; human; incidence; liver cell carcinoma; major clinical study; male; population research; priority journal; propensity score; retrospective study; acute kidney failure; causality; chemoembolization; liver cell carcinoma; liver tumor; middle aged; proportional hazards model; risk factor; Taiwan; Acute Kidney Injury; Aged; Carcinoma, Hepatocellular; Causality; Chemoembolization, Therapeutic; Cohort Studies; Female; Humans; Liver Neoplasms; Male; Middle Aged; Proportional Hazards Models; Retrospective Studies; Risk Factors; Taiwan |
顯示於: | 醫學院附設醫院 (臺大醫院) |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。